Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, MT Bhatti, J Jitprapaikulsan… - Neurology, 2020 - AAN Enterprises
Objective Myelin oligodendrocyte glycoprotein–immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …
被引用次数：180 相关文章
[PDF] academia.edu

[PDF][PDF] Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, J Jitprapaikulsan, D Dubey… - Neurology, 2020 - academia.edu
Objective Myelin oligodendrocyte glycoprotein–immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, MT Bhatti, J Jitprapaikulsan… - Neurology, 2020 - profiles.wustl.edu
Objective Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …
[HTML] nih.gov

[HTML][HTML] Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, MT Bhatti, J Jitprapaikulsan… - Neurology, 2020 - ncbi.nlm.nih.gov
Objective Myelin oligodendrocyte glycoprotein–immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, MT Bhatti, J Jitprapaikulsan… - Neurology, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> Myelin oligodendrocyte
glycoprotein–immunoglobulin G (MOG-IgG) associated disorder (MOGAD) often manifests …

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, MT Bhatti… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, MT Bhatti… - …, 2020 - mahidol.elsevierpure.com
Objective Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …
[HTML] umn.edu

[HTML][HTML] Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, MT Bhatti, J Jitprapaikulsan… - Neurology, 2020 - experts.umn.edu
OBJECTIVE: Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …
[PDF] medelement.com

[PDF][PDF] Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

JJ Chen, EP Flanagan, J Jitprapaikulsan… - …, 2020 - files.medelement.com
Objective Myelin oligodendrocyte glycoprotein–immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.

JJ Chen, EP Flanagan, MT Bhatti, J Jitprapaikulsan… - Neurology, 2020 - europepmc.org
Objective Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) associated
disorder (MOGAD) often manifests with recurrent CNS demyelinating attacks. The optimal …